USA Financial Formulas’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$181K Buy
+2,978
New +$174K 0.03% 127
2023
Q4
Sell
-21
Closed -$1.22K 370
2023
Q3
$1.22K Hold
21
﹤0.01% 388
2023
Q2
$1.34K Hold
21
﹤0.01% 350
2023
Q1
$1.46K Buy
+21
New +$1.48K ﹤0.01% 263
2022
Q3
$17K Buy
240
+200
+500% +$14.5K 0.03% 100
2022
Q2
$3K Sell
40
-5
-11% -$381 ﹤0.01% 172
2022
Q1
$3K Hold
45
﹤0.01% 198
2021
Q4
$3K Sell
45
-787
-95% -$46.2K ﹤0.01% 238
2021
Q3
$49K Buy
832
+787
+1,749% +$51.8K 0.04% 206
2021
Q2
$3K Buy
45
+4
+10% +$261 ﹤0.01% 283
2021
Q1
$3K Sell
41
-1,277
-97% -$79.5K ﹤0.01% 247
2020
Q4
$82K Buy
1,318
+1,264
+2,341% +$77.7K 0.06% 153
2020
Q3
$3K Buy
54
+41
+315% +$2.47K ﹤0.01% 193
2020
Q2
$1K Hold
13
﹤0.01% 148
2020
Q1
$1K Buy
+13
New +$795 ﹤0.01% 179
2019
Q1
Sell
-8,884
Closed -$552K 146
2018
Q4
$552K Buy
+8,884
New +$477K 0.14% 118
2016
Q3
Sell
-11,798
Closed -$868K 235
2016
Q2
$868K Buy
+11,798
New +$834K 0.24% 88
2015
Q3
Sell
-61,269
Closed -$4.08M 106
2015
Q2
$4.08M Buy
+61,269
New +$4.04M 1.25% 20

Other funds holding BMY

USA Financial Formulas's BMY Position: Q1 2026 in Review

USA Financial Formulas opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 2,978 shares worth $181K. The stake represents 0.03% of the portfolio and ranks #127 among its holdings. This is a return to the name: USA Financial Formulas previously reported a position in BMY as recently as Q3 2023.

USA Financial Formulas first reported a position in BMY in Q2 2015 and has held it in 18 quarters since. The position peaked at $4.08M in Q2 2015. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • USA Financial Formulas held 2,978 shares of Bristol-Myers Squibb worth $181K as of Q1 2026.
  • Bristol-Myers Squibb was a new USA Financial Formulas position in Q1 2026.
  • Bristol-Myers Squibb made up 0.03% of USA Financial Formulas's portfolio in Q1 2026, its #127 holding.
  • USA Financial Formulas first reported a position in Bristol-Myers Squibb in Q2 2015 and has held it in 18 quarters since.
  • USA Financial Formulas's Bristol-Myers Squibb position peaked at $4.08M in Q2 2015.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on USA Financial Formulas's 13F filing for Q1 2026, filed 14 Apr 2026.